NanJing Pharmaceutical Company Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 50,074.09 million compared to CNY 44,964.11 million a year ago. Revenue was CNY 50,221.56 million compared to CNY 45,123.2 million a year ago.

Net income was CNY 595.67 million compared to CNY 505.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.475 compared to CNY 0.485 a year ago. Diluted earnings per share from continuing operations was CNY 0.475 compared to CNY 0.485 a year ago.